John Markels

Insider Reports History

Entity
Individual
Location
C/O Sangamo Therapeutics, Inc., Point Richmond Tech Ctr, 501 Canal Blvd., Richmond, CA
Signature
/s/ Ilan Katz, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Markels:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcturus Therapeutics Holdings Inc. Director Common Stock 3.13K $100K $32.03 Jun 14, 2024 Direct
SANGAMO THERAPEUTICS, INC Director Common Stock 71.4K $42.8K $0.60 Jun 4, 2024 Direct
Arcturus Therapeutics Holdings Inc. Director Deferred Stock Units 0 $0 $32.03 Jun 14, 2024 Direct
SANGAMO THERAPEUTICS, INC Director Stock Option (Right to Buy) 50K Jun 4, 2024 Direct
Arcturus Therapeutics Holdings Inc. Director Stock option (right to buy) 15K Jun 14, 2024 Direct

Insider Reports Filed by John Markels

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARCT Arcturus Therapeutics Holdings Inc. Jun 14, 2024 3 $0 4 Jun 18, 2024 Director
SGMO SANGAMO THERAPEUTICS, INC Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
ARCT Arcturus Therapeutics Holdings Inc. Aug 1, 2023 2 $0 4 Aug 3, 2023 Director
SGMO SANGAMO THERAPEUTICS, INC Jun 1, 2023 2 $0 4 Jun 5, 2023 Director
ARCT Arcturus Therapeutics Holdings Inc. Dec 8, 2022 2 $0 4 Dec 13, 2022 Director
ARCT Arcturus Therapeutics Holdings Inc. Dec 8, 2022 0 $0 3 Dec 13, 2022 Director
SGMO SANGAMO THERAPEUTICS, INC Jun 3, 2022 1 $25K 4 Jun 6, 2022 Director
SGMO SANGAMO THERAPEUTICS, INC Feb 25, 2022 2 $0 4 Mar 1, 2022 Director